Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02423915
Title Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

hematologic cancer

Therapies

Filgrastim

Rituximab

Cyclophosphamide + Fludarabine + Mycophenolate mofetil

Sirolimus

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.